Gut Liver.
2014 Mar;8(2):117-130.
Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)
- Affiliations
-
- 1Division of Gastroenterology, University of California San Francisco School of Medicine, San Francisco, CA, USA. jallison@medsfgh.ucsf.edu
- 2Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
- 3Centre for Research into Cancer Prevention and Screening, University of Dundee School of Medicine, Dundee, Scotland.
- 4NHS Bowel Cancer Screening Southern Programme Hub, Royal Surrey County Hospital and University of Surrey, Guildford, UK.
- 5Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park SA, Australia.
Abstract
- Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Evaluation of the Cut-Off Value of Fecal Immunochemical Test for Colorectal Cancer Screening during Health Checkups
- The Significance of Fecal Immunochemical Test to Screen for Colorectal Cancer in National Cancer Screening Program
- Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
- Current Status of Colorectal Cancer and Its Public Health Burden in Thailand
- National cancer screening program for colorectal cancer in Korea
